DISCUSSION ON RAILWAY PAPER NO. 64: WORK STUDY AND ITS APPLICATION TO RAILWAY CIVIL ENGINEERING MAINTENANCE von PESCOD, PDT, CAMERON, JCF, CAMPION, FE, PRIOR, FJJ, HOPKINS, CP, LAMBERT, FL, MANTHEI, RA, DUNTON, CE, STANDING, B

Volltext

DISCUSSION ON PAPER NO. 6260: USE OF AERIAL PHOTOGRAPHY BY RAILWAYS von VINER BRADY, NEV, PEARSON, HM, BRADY, NEVV, CAMPION, FE, CAREY, LFDV, MOTT, PG, COOKSON, EC, HOTINE, M, MCILMOYLE, RL, GARLAND, JRA, HARVEY, RC, SMITH, WP, MERCER, CHH, WILLIS, JCT, MACRAE, MB, PONT, S, BRIDGMAN, R

Volltext

A longitudinal study of brain atrophy in relapsing multiple sclerosis von SIMON, J. H, JACOBS, L. D, SIMONIAN, N, LAJAUNIE, M, MILLER, D. E, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, MUNSCHAUER, F. E, BROWNSCHEIDLE, C. M, CAMPION, M. K, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GOODKIN, D. E

Volltext

Complex consultations and the 'edge of chaos' von Innes, Andrew D, Campion, Peter D, Griffiths, Frances E

Volltext

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis von RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Volltext

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis von RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Volltext

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis: Multiple sclerosis von RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Volltext

Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial von Pose, E, Napoleone, L, Amin, A, Campion, D, Jimenez, C, Piano, S, Roux, O, Uschner, FE, de Wit, K, Zaccherini, G, Alessandria, C, Angeli, P, Bernardi, M, Beuers, U, Caraceni, P, Durand, F, Mookerjee, RP, Trebicka, J, Vargas, V, Andrade, RJ, Carol, M, Pich, J, Ferrero, J, Domenech, G, Llopis, M, Torres, F, Kamath, PS, Abraldes, JG, Solà, E, Ginès, P

Volltext bestellen

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials von Goodkin, D E, Priore, R L, Wende, K E, Campion, M, Bourdette, D N, Herndon, R M, Fischer, J S, Jacobs, L D, Cookfair, D L, Rudick, R A, Richert, J R, Salazar, A M, Granger, C V, Simon, J H, Alam, J J, Bartoszak, D M, Braiman, J, Brownscheidle, C M, Coats, M E, Cohan, S L, Dougherty, D S, Kinke, R P, Mass, M K, Munschauer, F E, Pullicino, P M, Scherokman, B J, Weinstock-Guttman, B, Whitham, R H

Volltext